Vaccines comprising plasmodium antigens

Details for Australian Patent Application No. 2005284223 (hide)

Owner GlaxoSmithKline Biologicals s.a.

Inventors Cohen, Joseph D; Tornieporth, Nadia Gabriela

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005284223

PCT Pub. Number WO2006/029887

Priority 0420634.8 16.09.04 GB

Filing date 14 September 2005

Wipo publication date 23 March 2006

Acceptance publication date 15 December 2011

International Classifications

A61K 39/015 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/15 (2006.01) Medicinal preparations containing antigens or antibodies - Reoviridae, e.g. calf diarrhea virus

A61P 33/06 (2006.01) Antiparasitic agents

Event Publications

5 April 2007 PCT application entered the National Phase

  PCT publication WO2006/029887 Priority application(s): WO2006/029887

15 December 2011 Application Accepted

  Published as AU-B-2005284223

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005284244-Stable liquid formulations of plasmid DNA

2005284219-Method for producing single or multiply coated substrates with the aid of a coloured coating composition comprising a binding agent for adhesion